3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cisplatin
1041
Cyclophosphamide
974
Carboplatin
954
Radiotherapy
893
Bevacizumab
847
Gemcitabine
817
pembrolizumab
760
Paclitaxel
740
Docetaxel
734
Oxaliplatin
706
Capecitabine
650
Fluorouracil
564
Rituximab
559
Nivolumab
506
Dexamethasone
487
Etoposide
468
Doxorubicin
458
Irinotecan
442
Drug Therapy
402
Leucovorin
377
Cytarabine
342
Cetuximab
340
Lenalidomide
327
Trastuzumab
324
Pemetrexed
315
durvalumab
295
Filgrastim
287
Magnetic Resonance Spectroscopy
279
Temozolomide
275
Prednisone
274
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
OTHER
×
AIEOP acute lymphoblastic leukemia protocol
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled